TipRanks on MSN

Karolinska Development portfolio firm SVF Vaccines plans Nasdaq First North Premier listing via Novakand reverse takeover

Karolinska Development AB ( ($SE:KDEV) ) has provided an update. Karolinska Development’s portfolio company SVF Vaccines has signed a non-binding ...
The Manila Times

Karolinska Development’s portfolio company SVF Vaccines plans for listing on Nasdaq First North Premier through reverse takeover ahead of accelerated vaccine …

STOCKHOLM, Sweden, December 22, 2025. Karolinska Development AB (Nasdaq Stockholm: KDEV) announces that its portfolio company ...
The Pharma Letter

SVF Vaccines pursues Nasdaq First North listing via reverse takeover

Swedish life sciences investor Karolinska Development (Nasdaq Stockholm: KDEV) said its portfolio company SVF Vaccines has ...

Karolinska Development AB (publ): Karolinska Development's portfolio company SVF Vaccines plans for listing on Nasdaq First North Premier through reverse takeover ahead of ...

STOCKHOLM, Sweden, December 22, 2025. Karolinska Development AB (Nasdaq Stockholm: KDEV) announces that its portfolio company SVF Vaccines has signed a non-binding letter of intent (LOI) with Novakand ...

Karolinska Development's portfolio company Modus Therapeutics initiates dosing in phase 2a study in patients with chronic kidney disease with anemia

STOCKHOLM, SWEDEN December 10, 2025. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its portfolio company, Modus Therapeutics, has dosed the first patient in the phase 2a ...

Karolinska Development’s portfolio company SVF Vaccines presents new preclinical data demonstrating extended effect of SVF-001 in chronic hepatitis B and D

STOCKHOLM, Sweden, December 11, 2025. Karolinska Development AB (Nasdaq Stockholm: KDEV) announces that its portfolio company SVF Vaccines has presented new preclinical data on its immunotherapy ...